The Establishment and Validation of Reference Intervals for Plasma Pentraxin-3 in Healthy Volunteers and Patients with Takayasu's Arteritis

Xiang Zhou,Qing Han,Xiqing Wang,Ming Zhang,Xiang Li,Wenhui Ma,Xueying Wang,Weidong Yang,Ping Zhu,Jing Wang,Fei Kang

DOI: https://doi.org/10.1016/j.cca.2022.09.028

IF: 6.314

2022-01-01

Clinica Chimica Acta

Abstract:Background and aims: To establish reference intervals (RIs) for PTX-3 and to validate the performance of these RIs in a population including healthy volunteers and Takayasu's arteritis (TAK) patients. Materials and methods: Plasma PTX-3 levels were determined in 166 healthy volunteers and 63 TAK patients. RIs were established in healthy volunteers according to guidelines from the Clinical and Laboratory Standards Institute (CLSI, C28-A3). Global assessment was used to quantitatively diagnose active/non-active TAK patients. Screening and monitoring performances were validated by identifying active TAK patients from the whole population or diagnosed TAK patients. Results: The PTX-3 RI was calculated to be 0.87-2.78 ng/mL. For screening purposes, 1.55 ng/mL had a high sensitivity of 90.32 % and the RI upper limit (2.78 ng/mL) had a high specificity of 97.94 %. For monitoring purposes, the sensitivity/specificity of the cut-off value (1.55 ng/mL) and RI median were 90.32 %/90.63 % and 80.85 %/90.63 %, respectively. These screening and monitoring performances of PTX-3 were superior to those of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Conclusion: The distribution of serum PTX-3 levels was stable and uniform across the population. The screening and monitoring performances of the cut-off value and RI-derived values of PTX-3 were higher than CRP and ESR.